Frankfurt - Delayed Quote EUR
Zealand Pharma A/S (22Z.F)
53.46
-2.54
(-4.54%)
At close: May 15 at 9:02:35 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in DKK | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 9 | 13 |
| Avg. Estimate | 7.88B | 25.22M | 7.2B | 2.07B |
| Low Estimate | 37.19M | 8.4M | 2.18B | -- |
| High Estimate | 9.59B | 50M | 10.1B | 7.49B |
| Year Ago Sales | 34.13M | 4.42M | 62.69M | 7.2B |
| Sales Growth (year/est) | 22,996.16% | 471.19% | 11,389.76% | -71.24% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 22Z.F | -- | -- | -- | -- |
| S&P 500 | 13.17% | 2.85% | 7.92% | 13.78% |
Related Tickers
49BA.SG BeiGene Ltd
197.00
+0.51%
688235.SS BeiGene, Ltd.
223.88
-1.45%
BVNKF Bavarian Nordic A/S
26.80
0.00%
LSB LakeShore Biopharma Co., Ltd
1.0771
-4.68%
CDIOW Cardio Diagnostics Holdings, Inc.
0.0173
+63.21%
ADAG Adagene Inc.
1.7700
+1.14%
PRTC PureTech Health plc
17.35
+11.78%
APLM Apollomics, Inc.
4.6250
-5.23%
BVNRY Bavarian Nordic A/S
8.13
+2.39%
CHRO Channel Therapeutics Corporation
0.9600
-9.43%